Clinical Trials What Are They and What Do They Do?
This program has been supported by independent educational grants from Daiichi Sankyo Inc., Gilead Sciences, Inc., Merck & Co., Inc.; and Pfizer Inc.
Differences in the quality of healthcare in the United States (US) is related to many things, including age, race, ethnicity, gender, sexual orientation, socioeconomic status, or geographic location.
Join us for “Represent for You: Improving Equity in Lung and Breast Cancer Clinical Trials,” an hour-long lnteractive educational event on improving access to cancer clinical trials. An expert panel discusses why it is important for people r to participate in clinical trials that provide access to novel and breakthrough treatments. Panelists will examine common myths and misconceptions about clinical trials.
Some of the topics discussed:
- Removing barriers to participation in clinical trials
- Knowing your subtype and implications for treatment/eligibility
- Guide to discuss clinical trials with your team
- Eligibility criteria
- Genetic and molecular screening
- Overview of phases and risk-benefit ratio
- Expectations before, during, and after a clinical trial
Be sure to visit the Clinical Trial Resource Hub, which includes resources from advocacy organizations, at any time to find even more information.
Let's Talk About Health Equity Diversity and Inclusion
Removing Barriers to Participation in Clinical Trials
Is a Clinical Trial the Right Treatment for My Lung or Breast Cancer?
Real-Talk Patient Panel: Patients with Lung or Breast Cancer
Q & A and Advocacy Spotlights featuring Trial-Finder Information
Ricki Fairley, CEO and Co-Founder
TOUCH, The Black Breast Cancer Alliance
As a Triple Negative Breast Cancer Survivor/Thriver, Ricki Fairley’s personal purpose is to bring focus, attention, research, science, and action to eradicating Black Breast Cancer and supporting and coaching what she calls her “Breasties” through their breast cancer experience. Ricki is an award-winning seasoned marketing veteran that has transformed her strategic acumen into breast cancer advocacy. Ricki co-founded and serves as CEO of TOUCH, The Black Breast Cancer Alliance to address Black Breast Cancer as a unique and special disease state, with the overall goal of reducing the mortality rate for Black women. Ricki founded and is a co-host for “The Doctor Is In,” a weekly live breast cancer advocacy web series on the BlackDoctor.org Facebook page that reaches over 3 million viewers.
Susan Vadaparampil, PhD, MPH
Senior Member and Associate Center Director of Community Outreach, Engagement, & Equity
Co-Program Director, Moffitt Behavioral Oncology Postdoctoral Training Program Moffitt Cancer Center
Susan Vadaparampil, PhD, MD, is associate center director of Community Outreach, Engagement & Equity (COEE), and a senior member in the Health Outcomes and Behavior Program in the Division of Population Sciences at Moffitt Cancer Center in Tampa, Florida. Her work is influenced by transdisciplinary collaboration, focused on health disparities, and contributes to both the scientific literature and clinical practice. Dr Vadaparampil’s current research focuses on genetic counseling and testing for inherited cancer susceptibility, and breast and cervical cancer prevention/early detection. In 2019, she was awarded the American Cancer Society St. George National Award for over a decade of distinguished community service and contributions to HPV vaccination and cancer health disparities.
Aaron Lisberg, MD
Assistant Professor of Clinical Medicine
University of California, Los Angeles
Monique Gary, DO, FACS, FSSO
Breast Surgical Oncologist
Medical Director, Cancer Program
Grand View Health/Penn Cancer Network
Associate Professor of Surgery
Philadelphia College of Osteopathic Medicine
Interview Participant - Karen Peterson, Founder, Karen's Club, Stage IV TNBC Survivor
Interview Participant: Giancarlo, Lung cancer survivor
Interview Participant - LaToya Bolds-Johnson, PA-C Breast Cancer Thriver & HCP